69
Participants
Start Date
February 2, 2022
Primary Completion Date
November 25, 2022
Study Completion Date
January 18, 2023
Remimazolam Besylate 6 mg/kg/hr
Patients will receive remimazolam at 6 mg/kg/hr by continuous infusion until loss of consciousness.
Remimazolam Besylate 12 mg/kg/hr
Patients will receive remimazolam at 12 mg/kg/hr by continuous infusion until loss of consciousness.
Propofol
Patients will receive propofol at a target controlled infusion 4 µg/ml until loss of consciousness.
Ajou University Hospital, Suwon
Ajou University School of Medicine
OTHER